Rossari Biotech Ltd Q2 FY26 — When 4,280 Products Earn You 12% ROE and a Seat Next to Pidilite in the Attendance Register
1. At a Glance
If chemistry had a stand-up act, Rossari Biotech would open the show with a lab coat and a nervous smile. At ₹ 648 per share, market cap ₹ 3,589 cr, this “specialty-chemical” star has become a specialist in delivering steady growth with Bollywood-movie patience. Q2 FY26 revenue jumped 18 % YoY to ₹ 586 cr, but PAT crawled only 4 % to ₹ 37 cr. The OPM 12 % flatlined, ROE 12 %, ROCE 15.8 %, and yet the stock has slipped 21 % YoY—like a topper who still gets scolded for handwriting. The P/E 26× is half of Pidilite’s, but double of your comfort zone. So yes, chemistry is profitable; just not explosively so.
2. Introduction
Rossari started in 2003 mixing textile auxiliaries and dreams of global glory. Two decades later, it’s a mid-cap that smells faintly of detergent and ambition. Its three pillars—Home & Personal Care (HPPC), Textile Specialty Chemicals (TSC), and Animal Health & Nutrition (AHN)—cover everything from fabric softeners to poultry enzymes. Basically, from your shirt to your shampoo to your chicken—Rossari’s molecules are everywhere.
But investors wanted the next Pidilite; what they got was the next “patient compounding case study.” Margins hover around 12–13 %, management speaks fluent “capacity expansion,” and the chart looks like a sine wave of optimism and boredom.
3. Business Model – WTF Do They Even Do?
Let’s decode the periodic table of Rossari:
HPPC (76 %) – Cleaning chemicals, detergents, coatings, inks, ceramics, water-treatment blends—basically the stuff that makes other stuff shine. The fastest-growing segment and darling of FMCG tie-ups.
TSC (19 %) – Legacy textile aids: dyeing auxiliaries, finishing agents, digital printing chemistry. Once the core, now the side hustle.
AHN (5 %) – Poultry feed supplements, pet grooming and treats—because even chickens deserve glossy feathers.
They manufacture across 7 plants in Gujarat, 3.3 lakh MTPA total capacity, distribute through 406 distributors across 24 states, and export to 50 countries. Two R&D centres—Silvassa and IIT Bombay—churn out new molecules faster than SEBI circulars.
4. Financials Overview
Metric
Q2 FY26
Q2 FY25
Q1 FY26
YoY %
QoQ %
Revenue
₹ 586 cr
₹ 498 cr
₹ 544 cr
+17.6 %
+7.7 %
EBITDA
₹ 72 cr
₹ 66 cr
₹ 68 cr
+9 %
+6 %
PAT
₹ 37 cr
₹ 35 cr
₹ 34 cr
+4 %
+9 %
EPS (₹)
6.66
6.39
6.07
+4 %
+9 %
Annualised EPS ≈ ₹ 26.6 → P/E ≈ 24×
🧪 Commentary: Steady chemistry—no explosions, no leaks. Margins behaving like disciplined students in a lab safety video.
5. Valuation Discussion – Fair Value Range Only
(a) P/E Approach
Sector average ≈ 32× ; EPS ₹ 24.7 → Fair range ₹ 600 – ₹ 790.
